Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
2020;doi: 10.2337/dc19-1350), which examined the initiation of combination therapy with exenatide once-weekly (Bydureon, AstraZeneca) plus dapagliflozin (Farxiga, AstraZeneca) vs
We need to work more on engaging with payers and insurance companies to better model and understand where and how they are seeing the return on investment across their books, said Tracy Zvenyach, director of Policy Strategy & Alliances at the Obesity Action Coalition
Gen Comp Endocrinol (2017) 252:1429.10.1016/j.ygcen.2017.08.008 134 YoungRLChiaBIsaacsNJMaJKhooJWuTet alDisordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes
Peptide library approach to uncover phosphomimetic inhibitors of the BRCA1 C-terminal domain
US$ 22.71
US$ 26.89
US$ 28.02
US$ 21.49
US$ 21.58
US$ 25.68
US$ 22.27
US$ 21.17
US$ 26.44
US$ 22.02
US$ 20.48
